Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Novogene Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Novogene has a total shareholder equity of CN¥2.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.4B and CN¥986.8M respectively. Novogene's EBIT is CN¥179.4M making its interest coverage ratio -6.4. It has cash and short-term investments of CN¥1.3B.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -6.4x |
| Nakit | CN¥1.27b |
| Eşitlik | CN¥2.40b |
| Toplam yükümlülükler | CN¥986.84m |
| Toplam varlıklar | CN¥3.39b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Earnings Working Against Novogene Co., Ltd.'s (SHSE:688315) Share Price
Sep 27
Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%
Jun 07Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook
Apr 17Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)
Mar 25Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 688315's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥963.1M).
Uzun Vadeli Yükümlülükler: 688315's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥23.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 688315 is debt free.
Borcun Azaltılması: 688315 has no debt compared to 5 years ago when its debt to equity ratio was 2.2%.
Borç Kapsamı: 688315 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 688315 has no debt, therefore coverage of interest payments is not a concern.